The Mechanism by which TATA-Box Polymorphisms Associated with Human Hereditary Diseases Influence Interactions with the TATA-Binding Protein

Human Mutation

Volumn 35, Issue 5, 2014, Pages 601-608

  Drachkova, Irina ^a   Savinkova, Ludmila ^a   Arshinova, Tatyana ^a   Ponomarenko, Mikhail ^a   Peltek, Sergey ^a   Kolchanov, Nikolay ^a,b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Association rate; Dissociation rate; Hereditary disease; TATA box; TBP

Indexed keywords

BLOOD CLOTTING FACTOR 9; HEPATOCYTE NUCLEAR FACTOR 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MANNOSE BINDING LECTIN 2; TATA BINDING PROTEIN; THROMBOPLASTIN; TRIOSEPHOSPHATE ISOMERASE; TRANSCRIPTION FACTOR;

ALLELE; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DELTA THALASSEMIA; DISEASE SEVERITY; DNA STRAND; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HALF LIFE TIME; HEART INFARCTION; HEMOPHILIA B; HUMAN; LUNG CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TATA BOX; TRANSCRIPTION INITIATION SITE; GENETIC DISEASES, INBORN; GENETICS; KINETICS; MUTATION; PATHOLOGY;

GENETIC DISEASES, INBORN; HUMANS; KINETICS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TATA BOX; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRIOSE-PHOSPHATE ISOMERASE;

EID: 84898782328     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22535     Document Type: Article

References (48)

1. Antonarakis SE, Irkin SH, Cheng TC, Scott AF, Sexton JP, Trusko SP, Charache S, Kazazian HH Jr. 1984. Beta-thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. Proc Natl Acad Sci USA 81:1154-1158.
2. Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M. 2000. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Te.moins de l'Infarctus du Myocarde. Paris Thrombosis case-control study. Arterioscl Thromb Vasc Biol 20:892-898.
3. Badens C, Jassim N, Martini N, Mattei JF, Elion J, Lena-Russo D. 1999. Characterization of a new polymorphism, IVS-I-108 (TC), and a new beta-thalassemia mutation, -27 (AT), discovered in the course of a prenatal diagnosis. Hemoglobin 23:339-344.
4. Boldt AB., Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. 2006. Diversity of the MBL2 gene in various brasilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol 67:722-734.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Bucher P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 212:563-578.
7. Burgner D, Rockett K, Ackerman H, Hull J, Usen S, Pinder M, Kwiatkowski DP. 2003. Haplotypic relationship between SNP and microsarellite marcers at the NOS2A locus in two populations. Gen Immun 4:506-514.
8. Deato MD, Marr MT, Sottero T, Inouye C, Hu P, Tjian R. 2008. MyoD targets TAF3/TRF3 to activate myogenin transcription. Mol Cell 32:96-105.
9. De Graaf P, Mousson F, Geverts B, Scheer E, Tora L, Houtsmuller AB, Timmers HT. 2010. Chromatin interaction of TATA-binding protein is dynamically regulated in human cells. J Cell Sci 123:2663-2671.
10. De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, Cheng JF, Rubin EM, et al. 2006. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 312:1215-1217.
11. Dinan CT, Luijsterburg MS, Hofer T, Gesa von Bornstaedt, Vermeulen W, Houtsmuller AB, Roel van Driel. 2009. Assembly of multiprotein complexes that control genome function. J Cell Biol 185:21-26.
12. Drachkova IA, Repkova MN, Lysova MV, Arshinova TV, Savinkova LK. 2005. Interaction of proteins from general transcription complex RNA polymerase II with oligoribonucleotides. Mol Biol (Russia) 39:139-146.
13. Eisen DP, Minchinton RM. 2005. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37:1496-1505.
14. Flint J, Harding RM, Boyce AJ, Clegg JB. 1998. The population genetics of the hemoglobinopathies. Bailliere's Clin Hematol 11:1-50.
15. Frischknecht H, Dutly F. 2005. Two new delta-globin mutations: Hb A2-Ninive delta133 (H11) Val-Ala] and a delta(+)-thalassemia mutation [-31 (A -> G)] in the TATA box of the delta-globin gene. Hemoglobin 29:151-154.
16. Galanello R, Origa R. Beta thalassemia. Orphanet J Rare Diseases 2010. 5:11-27.
17. Gelinas R, Endlich B, Pfeiffer C, Yagi M, Stamatoyannopoulos G. 1985. G to A substitution in the distal CCAAT box of the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin. Nature 313:323-325.
18. Hahn S, Buratowski S, Sharp F, and Guarente L. 1989. Yeast TATA_binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences. Proc Natl Acad Sci USA 86:5718-5722.
19. Jain S, Edison ES, Mathews V, Shaji RV. 2012. A novel δ-globin gene mutation (HBD: c.323 G>A) masking the diagnosis of β-thalassemia: a first report from India. Int J Hematol 95:570-572.
20. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B. 2005. A high-resolution map of active promoters in the human genome. Nature 436:876-880.
21. Klages N, Strubin M. 1995. Stimulation of RNA polymerase II transcription initiation by recruitment of TBP in vivo. Nature 374:822-823.
22. Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, et al. 2008. Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410:129-138.
23. Levings PP, Bungert J. 2002. The human beta-globin locus control region. Eur J Biochem 269:1589-1599.
24. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. 1998. Different molecular events result in low protein levels of mannan-binding lectin in populations. J Immunol 161:3169-3175.
25. Martinez E, Zhou Q, L'etoile ND, Oelgeschlager T, Berk AJ, and Roeder RG. 1995. Core promoter-specific function of a mutant transcription factor TFIID defective in TATA-box binding. Proc Natl Acad Sci USA 92:11864-11868.
26. Muncie HL, Campbell JC. 2009. Alpha and beta thalassemia. A. Fam Phys 80:339-344.
27. Orkin SH, Sexton JP, Cheng TC, Goff SC, Giardina PJ, Lee JI, Kazazian HH Jr. 1983. ATA box transcription mutation in beta-thalassemia. Nucl Acids Res 11:4727-4734.
28. Papai G, Weil AP, and Schultz P. 2011. New insights into the function of transcription factor TFIID from recent structural studies. Curr Opin Genet Dev 21:219-224.
29. Patikoglou GA, Kim JL, Sun L, Yang SH, Kodadek T, Burley SK. 1999. TATA element recognition by the TATA box-binding protein has been conserved throughout evolution. Genes Dev 13:3217-3230.
30. Poncz M, Ballantine M, Solowiejczyk D, Barak I, Schwartz E, Surrey S. 1982. Beta-thalassemia in a Kurdish Jew. Single base changes in the T-A-T-A box. J Biol Chem 257:5994-5996.
31. Ponomarenko PM, Savinkova LK, Drachkova IA, Lysova MV, Ponomarenko MP, Kolchanov NA. 2008. A step-by-step model of TBP/TATA box binding allows predicting human hereditary diseases by single nucleotide polymorphism. Dokl Biochem Biophys 419:88-92.
32. Pugh BF. 1995. Purification of the human TATA-binding protein, TBP. In: Tymms MJ, editor. Methods in molecular biology: In vitro transcription and translation protocols. Totowa, NJ: Humana Press Inc. p 37.
33. Rockman MV, Wray GA. 2002. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 19:1991-2004.
34. Savinkova L, Drachkova I, Arshinova T, Ponomarenko P, Ponomarenko M, Kolchanov N. 2013. An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein. PLOS One 8(2):e54626.
35. Schechter A. 2008. Hemoglobin research and the origins of molecular medicine. Blood 112:3927-3938.
36. Steinberg MH, Adams JG. 1991. Hemoglobin A2: origin, evolution, and aftermath. Blood 78:2165-2177.
37. Stewart JJ, Stargell LA. 2001. The stability of the TFIIA-TBP-DNA complex dependent on the sequence of the TATAAA element. J Biol Chem 276:30078-30084.
38. Stewart JJ, Fischback JA, Chen X, Stargell LA. 2006. Non optimal TATA element exhibits diverse mechanistic consequences. J Biol Chem 281:22665-22673.
39. Surrey S, Delgrosso K, Malladi P, Schwartz E. 1985. Functional analysis of a beta-globin gene containing a TATA box mutation from a Kurdish Jew with beta thalassemia. J Biol Chem 260:6507-6510.
40. +-thalassemia. Blood 67:547-550.
41. Thein SL. 2005. Pathophysiology of β-thalassemia-A guide to molecular therapies. Am Soc Hematol Educ Program 2005:31-37.
42. Thomas MC and Chiang CM. 2006. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41:105-178.
43. Tjian R. 1996. The biochemistry of transcription in eukaryotes: a paradigm for multisubunit regulatory complexes. Philos Trans R Soc Lond B Biol Sci 351:491-499.
44. Verrijzer CP, Tjian R. 1996. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem Sci 21:338-42.
45. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiratori Y, Ito Y, Omata M. 2003 Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37:66-71.
46. Watanabe M, Zingg BC, Mohrenweiser HW, 1996. Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus. Am J Hum Genet 58:308-316.
47. Wobbe CR, Struhl K. 1990. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro. Mol Cell Biol 10:3859-3867.
48. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. 2004. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Cancer 109:353-356.